← Leaderboards
Martin Schneider
University Of Utah
$555,134
Attributed
$3,607,468
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$3,607,468 · 1
By mechanism
U01$3,607,468 · 1
Top collaborators
- Jane C. Figueiredo2 shared
- David Shibata2 shared
- Erin Siegel2 shared
- Adetunji T Toriola2 shared
- Cornelia M Ulrich2 shared
- Christopher I Li1 shared
Most similar at University Of Utah
Same institution · by research overlap
- Martha Or Marty L Slattery$38,713,014
- Ken R Smith$12,200,387
- Wendy K Kohlmann$1,590,442
- Evin Gulbahce$537,032
- Doratha Armenthus Byrd$1,387,508
Others in their field
Other Emerging Leaders on “Anticancer Research”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,320,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$161,112,755
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Dwayne Forquer · Leidos Biomedical Research, Inc.$29,410,041
- Leonard Freedmand · Leidos Biomedical Research, Inc.$22,652,885
Research focus
Anticancer ResearchBaseBehavioralBiobankBiological MarkersBloodBlood-Based BiomarkerBlood SpecimenCancer Health DisparityCancer PrognosisCancer SurvivorshipCessation Of LifeClinical DataCohortCohort StudiesCollaborationsCollectionColon Cancer PatientsColorectal CancerColorectal Cancer TreatmentCommunitiesData HarmonizationData ReportingAncillary Study